Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
Clinical trial NCT02406014 · COMPLETED
Trial details
- NCT number
- NCT02406014
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-06-01
- Enrollment
- 502
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.